Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
Incyte Corporation
Acerta Pharma BV
Celgene
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
Mayo Clinic
Arbeitsgemeinschaft medikamentoese Tumortherapie
Fred Hutchinson Cancer Center
Mayo Clinic
Duke University